feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
LIDDS: Ny preklinisk data med STING-agonister
Research Note
2018-07-30
11:24
LIDDS meddelade i dag nya prekliniska data från STING-agonister formulerade med NanoZolid.
MS
Mathias Spinnars
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans